Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
FUSED HETEROCYCLIC DERIVATIVES HAVING SELECTIVE BACE1 INHIBITORY ACTIVITY
Document Type and Number:
WIPO Patent Application WO/2020/009179
Kind Code:
A1
Abstract:
The present invention provides a compound which has an effect of inhibiting amyloid β production, especially an effect of inhibiting BACE1, and which is useful as a therapeutic or prophylactic agent for diseases induced by production, secretion and/or deposition of amyloid β proteins. A compound of Formula (I) wherein Ring A is THP optionally substituted with R3 s or the like; R2 is C1-C3 alkyl optionally substituted with halogen; R3 is each independently C1-C8 alkyl optionally substituted with one or more group(s) selected from halogen, cyano, C1-C3 alkyloxy, C1-C3 haloalkyloxy, 3- to 6-membered non-aromatic carbocyclyl optionally substituted with halogen, and 3- to 6-membered non-aromatic heterocyclyl optionally substituted with halogen, or the like; t is integer from 0 to 3; A1 is CR6 or N; A2 is CR10 or N; R5 is a hydrogen atom or halogen; R6 is a hydrogen atom or the like; R8 is a hydrogen or the like; R10 is a hydrogen atom or the like; Ring B is pyrazine substituted with cyano or the like; or its pharmaceutically acceptable salt.

Inventors:
YOSHIDA SYUHEI (JP)
TADANO GENTA (JP)
YAMADA TORU (JP)
OGUMA TAKUYA (JP)
KUSAKABE KEN-ICHI (JP)
ROMBOUTS FREDERIK (BE)
MISALE ANTONIO (ES)
Application Number:
PCT/JP2019/026598
Publication Date:
January 09, 2020
Filing Date:
July 04, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHIONOGI & CO (JP)
JANSSEN PHARMACEUTICA NV (BE)
International Classes:
C07D498/04; A61K31/5365; A61P25/28
Domestic Patent References:
WO2012107371A12012-08-16
Foreign References:
JP2012250933A2012-12-20
US20150166491A12015-06-18
JP2017071603A2017-04-13
Attorney, Agent or Firm:
SUGITA, Ken-ichi et al. (JP)
Download PDF: